艾可瑞妥单抗
Anti-Human CD3ExCD20 (Epcoritamab; GEN3013)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CD3ExCD20 (Epcoritamab; GEN3013)
CAS2134641-34-0
Storage conditionstore at -20°C
Security information
Product details

Epcoritamab, a CD3xCD20 bispecific antibody, effectively redirects T-cells to CD20+ B-cell tumors, demonstrating potent anti-tumor activity in DLBCL, FL, and MCL, regardless of prior CD20 antibody treatment .

Related
Sorry, no related items
History
Anti-Human CD30 Monoclonal Antibody(Iratumumab)
Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266)
Ozoralizumab
Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)
Anti-Human CD3ExCD20 (Epcoritamab; GEN3013)
Abituzumab (Anti-Integrin aV / ITGAV / CD51)
Trevogrumab (Synonyms: REGN-1033)
Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A; R07030816;CD20-TDB; RG7828; CD20 CD3 bispecific antibody.)
Anti-TIM3 (cobolimab biosimilar) mAb
Ramucirumab; LY3009806; IMC-1121B